Stayble Therapeutics News and Activities

Stayble Therapeutics is a company listed under the stock ticker STABLBTA (SE).

View the org chart displaying its 9 main executives

Most searched biographies at Stayble Therapeutics

• Andreas Gerward, Chief Executive Officer
• Erik Kinnman, Board Member
• Jane Buus Laursen, Board Member

Create your alert
to follow the executive moves at Stayble Therapeutics.

Stayble Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Stayble Therapeutics

• Press releases - Stayble Therapeutics
• News - Stayble Therapeutics

Social media about Stayble Therapeutics

• Stayble Therapeutics on Wikipedia, Google News & Yahoo Finance
• Stayble Therapeutics on LinkedIn, X (Twitter) & YouTube